WAVE Life Sciences

$4.34 0.00% ($0.00)

Get ready to invest

About WAVE Life Sciences

WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.

Popular Stocks	Price	Change
Snap SNAP	$55.14 8.44%	8.44%
Intel INTC	$49.46 0.7%	0.7%
Itau ITUB	$4.13 0.24%	0.24%
Petrobras PBR	$9.95 1.64%	1.64%
Banco Bradesco Pref Shares BBD	$3.6 1.64%	1.64%
Ford F	$16.28 0.31%	0.31%
Cleveland-Cliffs CLF	$23.85 7.19%	7.19%
Apple AAPL	$148.69 0.52%	0.52%
Ambev ABEV	$2.62 1.95%	1.95%